skip to content
Primary navigation

Required activities

Providers who are required to participate in the QI program are notified of their QI status when they receive their annual opioid prescribing report. After receiving their report, providers should confirm receipt by sending an email to  

2021 Quality improvement program requirements

Quality improvement (QI) activities in 2021 emphasize understanding one’s prescribing data and possible gaps in care, identifying specific barriers to change and securing resources to support change. Required QI activities include:


  • Opioid Prescribing Improvement Program Attestation (DHS-8143) (PDF): Providers use this form to attest to their understanding of the QI project, the work that must be completed and information about QI support. Providers also use this form to confirm current practice locations.
  • Special cause request for clinical review form (optional): This form must be requested from Minnesota Department of Human Services (DHS). This is an option for providers who would like to provide information about their practice—including summary clinical data—that explains why their prescribing exceeds community standards. DHS and Institute for Clinical Systems Improvement (ICSI) will review these forms within 30 days of receipt and, in some cases, will grant providers alternatives to quality improvement.
  • Opioid Prescribing Quality Improvement Report Form (DHS-8142) (PDF): This QI report collects summary information about your quality improvement project and will be submitted to DHS at the end of the year for review and approval. The report should be completed after the quality improvement project is complete. The form follows the process provided in the Opioid Prescribing Improvement Guide, but can be used to report any quality improvement approach. The report will be reviewed by your clinical peers for approval.

Project resources

  • ICSI Opioid Prescribing Improvement Guide: The ICSI Improvement Guide should be used by prescribers to plan, implement and document their quality improvement work. The guide also includes information for health care organizations that are building systems to support safer opioid prescribing practices. The guide includes tested strategies and a leader guide.
  • ICSI Opioid Post-Operative Prescribing Toolkit: This toolkit was developed by members of the MN Health Collaborative. This resource focuses on the initial postoperative discharge and post-acute phase of opioid prescribing. The toolkit includes procedure-specific MME benchmark goals developed by surgical departments across Minnesota.
  • ICSI Quality Improvement Webinars: ICSI hosted a series of webinars in support of the OPIP quality improvement program. Topics are geared towards health system leadership, quality improvement staff, and prescribers. 
  • MHA Opioid Roadmaps: Designed for organizations and individual practitioners, these roadmaps provide evidence-based recommendations and standards for the development of prevention and quality improvement programs and is intended to align process improvements with outcome data.    

Minnesota Opioid Prescribing Guidelines: The Minnesota Opioid Prescribing Guidelines focus on guidance for prescribing opioid therapy in ambulatory settings. The recommendations address acute pain, post-acute pain (up to 45 days following an acute event) and chronic pain. Revised taper guidance was finalized in 2021.

back to top